These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11547751)

  • 1. Race and responsiveness to drugs for heart failure.
    Masoudi FA; Havranek EP
    N Engl J Med; 2001 Sep; 345(10):767; author reply 767-8. PubMed ID: 11547751
    [No Abstract]   [Full Text] [Related]  

  • 2. Race and responsiveness to drugs for heart failure.
    Ofili E; Flack J; Gibbons G
    N Engl J Med; 2001 Sep; 345(10):767; author reply 767-8. PubMed ID: 11547752
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of race in heart failure therapy.
    Yancy CW
    Curr Cardiol Rep; 2002 May; 4(3):218-25. PubMed ID: 11960591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race and responsiveness to drugs for heart failure.
    Bovet P; Paccaud F
    N Engl J Med; 2001 Sep; 345(10):766; author reply 767-8. PubMed ID: 11547750
    [No Abstract]   [Full Text] [Related]  

  • 5. Are there ethnic differences in heart failure medication response?
    McBride BF; White CM
    Conn Med; 2003; 67(10):605-8. PubMed ID: 14677341
    [No Abstract]   [Full Text] [Related]  

  • 6. What's right (and wrong) with racially stratified research and therapies.
    Sade RM
    J Natl Med Assoc; 2007 Jun; 99(6):693-6. PubMed ID: 17595943
    [No Abstract]   [Full Text] [Related]  

  • 7. Racial response to angiotensin-converting enzyme therapy in systolic heart failure.
    Dries DJ; Yancy CW; Strong MA; Drazner MH
    Congest Heart Fail; 2004; 10(1):30-3. PubMed ID: 14872155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For the patient. New treatments for heart failure in Black people. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):150. PubMed ID: 12723027
    [No Abstract]   [Full Text] [Related]  

  • 9. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV; Dries DL; Domanski MJ; Cohn JN
    N Engl J Med; 2001 May; 344(18):1351-7. PubMed ID: 11333991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of race in the pharmacotherapy of heart failure.
    Kalus JS; Nappi JM
    Ann Pharmacother; 2002 Mar; 36(3):471-8. PubMed ID: 11895062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the response to drugs--pointers to genetic differences.
    Wood AJ
    N Engl J Med; 2001 May; 344(18):1394-6. PubMed ID: 11336055
    [No Abstract]   [Full Text] [Related]  

  • 13. Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure.
    El-Refai M; Hrobowski T; Peterson EL; Wells K; Spertus JA; Williams LK; Lanfear DE
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):591-6. PubMed ID: 24842464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.
    Yancy CW; Fowler MB; Colucci WS; Gilbert EM; Bristow MR; Cohn JN; Lukas MA; Young ST; Packer M;
    N Engl J Med; 2001 May; 344(18):1358-65. PubMed ID: 11333992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and outcomes for congestive heart failure by race/ethnicity in TRICARE.
    Bagchi AD; Stewart K; McLaughlin C; Higgins P; Croghan T
    Med Care; 2011 May; 49(5):489-95. PubMed ID: 21422958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does any evidence exist to treat heart failure based on race or ethnicity?].
    Latado AL; Lopes MB; Passos LC; Lopes AA
    Rev Assoc Med Bras (1992); 2009; 55(2):110-6. PubMed ID: 19488642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: heart failure in African Americans.
    Yancy CW
    Congest Heart Fail; 2004; 10(1):12. PubMed ID: 14872152
    [No Abstract]   [Full Text] [Related]  

  • 18. Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy.
    Kazi D; Deswal A
    Heart Fail Clin; 2005 Apr; 1(1):25-37. PubMed ID: 17386831
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart failure in African Americans: pathophysiology and treatment.
    Yancy CW
    J Card Fail; 2003 Oct; 9(5 Suppl Nitric Oxide):S210-5. PubMed ID: 14583891
    [No Abstract]   [Full Text] [Related]  

  • 20. Racial differences in the outcome of left ventricular dysfunction.
    Dries DL; Exner DV; Gersh BJ; Cooper HA; Carson PE; Domanski MJ
    N Engl J Med; 1999 Feb; 340(8):609-16. PubMed ID: 10029645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.